combine@alvar.ug

Hazardous alcohol consumption is not associated with CD4+T-cell count decline among PLHIV in Kampala Uganda: A prospective cohort study

Hazardous alcohol consumption is not associated with CD4+T-cell count decline among PLHIV in Kampala Uganda: A prospective cohort study

Show simple record

dc.contributor.author Wandera, Bonnie
dc.contributor.author Tumwesigye, Nazarius M.
dc.contributor.author Nankabirwa, Joaniter I.
dc.contributor.author Kambugu, Andrew D.
dc.contributor.author Mafigiri, David K.
dc.contributor.author Kapiga, Saidi
dc.contributor.author Sethi, Ajay K.
dc.date.accessioned 2021-01-01T21:58:17Z
dc.date.available 2021-01-01T21:58:17Z
dc.date.issued 2017
dc.identifier.issn 1932-6203
dc.identifier.uri http://combine.alvar.ug/handle/1/48250
dc.description.abstract Introduction There is limited data on the effects of alcohol on immunological response among persons living with HIV (PLHIV) in sub-Saharan Africa. We assessed the relationship between hazardous alcohol use and CD4+ T-cell count, among PLHIV in Uganda. Methods PLHIV aged >= 18 years were enrolled in a cohort study at the Infectious diseases clinic Kampala, Uganda. Alcohol consumption was assessed at enrolment (baseline) and 6 monthly thereafter using the alcohol use disorders identification test (AUDIT). The CD4+ T-cell counts, assessed at baseline and over the next 12 months were compared between alcohol use strata, using linear mixed effects regression. Using longitudinal mediation analysis methods, we estimated the effect of alcohol induced ART non-adherence on CD4+ T-cell count. Results Of the 1566 participants enrolled, 863(44.1%) were non-alcohol users (AUDIT score = 0), 433(27.7%) were non-hazardous (AUDIT score 1 - 7) alcohol users while 270 (17.2%) were hazardous (AUDIT score >= 8) alcohol users. The overall median (IQR) baseline CD4+ T-cell count was 356 (243 - 516) cells/mu l. There were no differences in the median baseline CD4+ T-cell count between hazardous and nonhazardous alcohol users compared to non-alcohol users in both the non-ART (p = 0.43) and ART group (p = 0.77). The mean CD4+ T-cell count over 12 months was not different between hazardous alcohol users and non-alcohol users (non-ART group p = 0.88 and ART group p = 0.62), nor between non-hazardous alcohol users and non-alcohol users (and non-ART group p = 0.66 and ART group p = 0.20). Alcohol use was not associated with a significant natural direct effect on CD4(+) T-cell count (1.37 95% CI [-1.78, 4.52] cells/mu l, p = 0.39) but had a statistically significant natural indirect effect on reduction of CD4(+) T-cell count (-0.91 cells/mu l [-1.36, -0.45], p < 0.001) mediated through ART non-adherence. Conclusion Hazardous alcohol use among PLHIV was not directly associated with lower CD4+ T-cell count but had a significant natural indirect effect on CD4+ T-cell count mediated through ART non-adherence. Among PLHIV with lower than expected CD4+ T-cell count, alcohol consumption should be excluded as an underlying factor for non-adherence to ART and any interventions targeting alcohol use should tackle possible ART non-adherence.
dc.description.sponsorship Wellcome Trust Training of Health Researchers into Vocational Excellence in East Africa (THRIVE) consortium [087540]
dc.description.sponsorship Infectious Diseases Institute, Makerere College of Health Sciences
dc.language English
dc.publisher PUBLIC LIBRARY SCIENCE
dc.relation.ispartof PLOS One
dc.title Hazardous alcohol consumption is not associated with CD4+T-cell count decline among PLHIV in Kampala Uganda: A prospective cohort study
dc.type Article
dc.identifier.isi 000404608700054
dc.identifier.doi 10.1371/journal.pone.0180015
dc.identifier.pmid 28665974
dc.publisher.city SAN FRANCISCO
dc.publisher.address 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
dc.identifier.volume 12
dc.identifier.issue 6
dc.subject.wc Multidisciplinary Sciences
dc.subject.sc Science & Technology - Other Topics
dc.description.oa DOAJ Gold
dc.description.oa Green Published
dc.description.oa Green Accepted
dc.description.pages 13
dc.subject.kwp Hiv Disease Progression
dc.subject.kwp Antiretroviral Adherence
dc.subject.kwp Use Disorders
dc.subject.kwp Infection
dc.subject.kwp Immunodeficiency
dc.subject.kwp Metaanalysis
dc.subject.kwp Individuals
dc.subject.kwp Therapy
dc.subject.kwp Health
dc.subject.kwp Impact
dc.identifier.articleno e0180015
dc.description.affiliation Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda
dc.description.affiliation Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda
dc.description.affiliation Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda
dc.description.affiliation Makerere Univ, Coll Humanities & Social Sci, Dept Social Work & Social Adm, Kampala, Uganda
dc.description.affiliation London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England
dc.description.affiliation Mwanza Intervent Trials Unit, Mwanza, Tanzania
dc.description.affiliation Univ Wisconsin Madison, Dept Populat Hlth Sci, Madison, WI USA
dc.description.email bonniewandera@gmail.com
dc.description.corr Wandera, B (corresponding author), Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda.; Wandera, B (corresponding author), Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda.
dc.description.orcid Kapiga, Saidi/0000-0003-1753-4060
dc.description.orcid Mafigiri, David/0000-0002-2699-4248


This record appears in the collections of the following institution(s)

Show simple record

Search Entire Database


Browse

My Account